KinoPharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.35M

  • Investors
  • 13

KinoPharma General Information

Description

Developer of molecule drugs intended to provide antiviral drugs to women for papillomavirus (HPV) infection. The company's research responds to the discovery and clinical development of next-generation antiviral drugs using an approach different from conventional antiviral drug strategies, enabling women to treat cervical cancer before it develops.

Contact Information

Website
www.kinopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nihonbashi Life Science Building 2, 705, 3-11-5
  • Nihonbashi Honcho
  • Tokyo, 103-0023
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Nihonbashi Life Science Building 2, 705, 3-11-5
  • Nihonbashi Honcho
  • Tokyo, 103-0023
  • Japan
+81

KinoPharma Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KinoPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 31-Jul-2023 $3.35M Completed Clinical Trials - Phase 2
9. Secondary Transaction - Private 01-Mar-2023 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series D) 10-Dec-2021 Completed Clinical Trials - Phase 2
7. Later Stage VC 31-Mar-2020 Completed Startup
6. Later Stage VC Completed Startup
5. Later Stage VC Completed Startup
4. Later Stage VC Completed Startup
3. Later Stage VC 14-Sep-2018 Completed Startup
2. Later Stage VC 27-Dec-2016 $605K $605K Completed Startup
1. Seed Round 01-Jan-2008 Completed Startup
To view KinoPharma’s complete valuation and funding history, request access »

KinoPharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class G
Class F
Class E
Class D
Class C
Class B 300 $2125.61 $2125.61 1x $2125.61 4.38%
Class A 700 $708.54 $708.54 1x $708.54 10.22%
To view KinoPharma’s complete cap table history, request access »

KinoPharma Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

KinoPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7406778-B1 External skin preparation containing aniline derivatives Active 02-May-2022
EP-4238565-A1 Pharmaceutical composition for preventing or treating viral perivaginal disease Pending 28-Oct-2020
CA-3199945-A1 Pharmaceutical composition for preventing or treating viral perivaginal disease Pending 28-Oct-2020
US-20230398107-A1 Pharmaceutical composition for preventing or treating viral perivaginal disease Pending 28-Oct-2020
EP-4159214-A1 Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus Pending 02-Jun-2020 A61K31/4545
To view KinoPharma’s complete patent history, request access »

KinoPharma Executive Team (3)

Name Title Board Seat
Masashi Kuroishi Co-Founder, Chief Executive Officer & President
Hiroshi Onoki Co-Founder, Board Member, Chief Operating Officer & Research & Development Manager
Katsuhiko Sato Chief Development Officer, Director & Head of Clinical Development Department
To view KinoPharma’s complete executive team members history, request access »

KinoPharma Board Members (3)

Name Representing Role Since
Hiroshi Onoki KinoPharma Co-Founder, Board Member, Chief Operating Officer & Research & Development Manager
Yoshiaki Someya Self Board Member
You’re viewing 2 of 3 board members. Get the full list »

KinoPharma Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Resona Capital Corporate Venture Capital Minority
Clinifer Holding Company Minority
Future Venture Capital Venture Capital Minority
Health Tech Group Corporation Minority
Iwaki Seiyaku Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

KinoPharma FAQs

  • When was KinoPharma founded?

    KinoPharma was founded in 2005.

  • Who is the founder of KinoPharma?

    Masashi Kuroishi and Hiroshi Onoki are the founders of KinoPharma.

  • Who is the CEO of KinoPharma?

    Masashi Kuroishi is the CEO of KinoPharma.

  • Where is KinoPharma headquartered?

    KinoPharma is headquartered in Tokyo, Japan.

  • What industry is KinoPharma in?

    KinoPharma’s primary industry is Drug Discovery.

  • Is KinoPharma a private or public company?

    KinoPharma is a Private company.

  • What is the current valuation of KinoPharma?

    The current valuation of KinoPharma is .

  • What is KinoPharma’s current revenue?

    The current revenue for KinoPharma is .

  • How much funding has KinoPharma raised over time?

    KinoPharma has raised $29.9M.

  • Who are KinoPharma’s investors?

    Resona Capital, Clinifer, Future Venture Capital, Health Tech Group, and Iwaki Seiyaku are 5 of 13 investors who have invested in KinoPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »